Sheller Spat Over FDA Risperdal Petition Denial Axed
The Third Circuit affirmed Thursday that Sheller PC lacks standing to challenge the U.S. Food and Drug Administration's denial of a citizen petition requesting revocation of the agency's approval for Risperdal...To view the full article, register now.
Already a subscriber? Click here to view full article